Stroke complicating percutaneous coronary intervention in patients with acute myocardial infarction

Circulation Journal

Volumn 71, Issue 9, 2007, Pages 1370-1375

  Kawamura, Akio ^a,b   Lombardi, Daniel A ^a   Tilem, Matthew E ^a   Gossman, David E ^a   Piemonte, Thomas C ^a   Nesto, Richard W ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Catheterization; Cerebral infarction; Complications

Indexed keywords

CREATININE;

ACUTE HEART INFARCTION; ADULT; AGED; AORTA BALLOON; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EMERGENCY CARE; FEMALE; HEART EJECTION FRACTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROLOGIC DISEASE; PERCUTANEOUS CORONARY INTERVENTION; RISK; STROKE; VEIN GRAFT;

ACUTE DISEASE; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CREATININE; DIABETIC ANGIOPATHIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; STROKE VOLUME; TIME FACTORS; TRANSPLANTS;

EID: 34548488478     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1370     Document Type: Article

References (31)

1. Dorros G, Cowley MJ, Simpson J, Bentivoglio LG, Block PC, Bourassa M, et al. Percutaneous transluminal coronary angioplasty: Report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation 1983; 67: 723-730.
2. Bredlau CE, Roubin GS, Leimgruber PP, Douglas JS Jr, King SB III, Gruentzig AR. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 1985; 72: 1044-1052.
3. Brown DL, Topol EJ. Stroke complicating percutaneous coronary revascularization. Am J Cardiol 1993; 72: 1207-1209.
4. Weintraub WS, Mahoney EM, Ghazzal ZMB, King SB III, Culler SD, Morris DC, et al. Trends in outcome and costs of coronary intervention in the 1990s. Am J Cardiol 2001; 88: 497-503.
5. Segal AZ, Abernethy WB, Palacios IF, BeLue R, Rordorf G. Stroke as a complication of cardiac catheterization: Risk factors and clinical features. Neurology 2001; 56: 975-977.
6. Fuchs S, Stabile E, Kinnaird TD, Mintz GS, Gruberg L, Canos DA, et al. Stroke complicating percutaneous coronary intervention: Incidence, predictors, and prognostic implications. Circulation 2002; 106: 86-91.
7. Dukkipati S, O'Neill WW, Harjai KJ, Sanders WP, Deo D, Boura JA, et al. Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J Am Coll Cardiol 2004; 43: 1161-1167.
8. Wong SC, Minutello R, Hong MK. Neurological complications following percutaneous coronary interventions (A report from the 2000-2001 New York State Angioplasty Registry). Am J Cardiol 2005; 96: 1248-1250.
9. Batchelor WB, Anstrom KJ, Muhlbaier LH, Grosswald R, Weintraub WS, O'Neill WW, et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: Results in 7,472 octogenarians. J Am Coll Cardiol 2000; 36: 723-730.
10. Komrad MS, Coffey CE, Coffey KS, McKinnis R, Massey EW, Califf RM. Myocardial infarction and stroke. Neurology 1984; 34: 1403-1409.
11. Budaj A, Flasinska K, Gore JM, Anderson FA Jr, Dabbous OH, Spencer FA, et al. Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes: Findings from a Global Registry of Acute Coronary Events. Circulation 2005; 111: 3242-3247.
12. Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002; 90: 358-363.
13. Cronin L, Mehta SR, Zhao F, Pogue J, Budaj A, Hunt D, et al. Stroke in relation to cardiac procedures in patients with non-ST-elevation acute coronary syndrome: A study involving >18000 patients. Circulation 2001; 104: 269-274.
14. Thompson PL, Robinson JS. Stroke after acute myocardial infarction: Relation to infarct size. BMJ 1978; 2: 457-459.
15. Sloan MA, Plotnick GD. Stroke complicating thrombolytic therapy of acute myocardial infarction. J Am Coll Cardiol 1990; 16: 541-544.
16. Longstreth WT Jr, Litwin PE, Weaver WD; The MITI Project Group. Myocardial infarction, thrombolytic therapy, and stroke: A community-based study. Stroke 1993; 24: 587-590.
17. Tanne D, Gottlieb S, Hod H, Reicher-Reiss H, Boyko V, Behar S, for the SPRINT and Israeli thrombolytic survey groups. Incidence and mortality form early stroke associated with acute myocardial infarction in the prethrombolytic and thrombolytic eras. J Am Coll Cardiol 1997; 30: 1484-1490.
18. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe J, et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: The primary angioplasty in myocardial infarction (PAMI) trial. J Am Coll Cardiol 1995; 25: 370-377.
19. O'Connor CM, Califf RM, Massey EW, Mark DB, Kereiakes DJ, Candela RJ, et al. Stroke and acute myocardial infarction in the thrombolytic era: Clinical correlates and long-term prognosis. J Am Coll Cardiol 1990; 16: 533-540.
20. Maggioni AP, Franzosi MG, Santoro E, White H, Van de Werf F, Tognoni G, et al. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. N Engl J Med 1992; 327: 1-6.
21. McClements BM, Weyman AE, Newell JB, Picard MH. Echocardiographic determinants of left ventricular ejection fraction after acute myocardial infarction. Am Heart J 2000; 140: 284-290.
22. Kalra A, Jang IK. Prevalence of early left ventricular thrombus after primary coronary intervention for acute myocardial infarction. J Thromb Thrombolysis 2000; 10: 133-136.
23. Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 1999; 99: 2079-2084.
24. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham study. Stroke 2001; 32: 2575-2579.
25. Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 2002; 105: 1412-1415.
26. James SK, Armstrong P, Barnathan E, Califf R, Lindahl B, Siegbahn A, et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: A GUSTO-IV substudy. J Am Coll Cardiol 2003; 41: 916-924.
27. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003; 348: 1104-1111.
28. Lincoff AM, Kereiakes DJ, Mascelli MA, Deckelbaum LI, Barnathan ES, Patel KK, et al. Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation 2001; 104: 163-167.
29. Akkerhuis KM, Deckers JW, Lincoff AM, Tcheng JE, Boersma E, Anderson K, et al. Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. JAMA 2001; 286: 78-82.
30. Lombardo A, Biasucci LM, Lanza GA, Coli S, Silvestri P, Cianflone D, et al. Inflammation as a possible link between coronary and carotid plaque instability. Circulation 2004; 109: 3158-3163.
31. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983-989.